Patients' attitudes and prior treatments in neuropathic pain: A pilot study

Pain Research and Management

Volumn 7, Issue 4, 2002, Pages 199-203

  Gilron, Ian ^a   Bailey, Joan ^a   Weaver, Donald F ^a   Houlden, Robyn L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Analgesic drug development; Barriers to treatment; Chronic nonmalignant pain; Diabetic neuropathy; Neuropathic pain; Pain measurement; Postherpetic neuralgia; Practice patterns; Randomized, controlled trials

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CAPSAICIN; CARBAMAZEPINE; CLONAZEPAM; CODEINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CREAM; DIABETIC NEUROPATHY; DISEASE DURATION; DOCTOR PATIENT RELATION; DRUG DEPENDENCE; FEMALE; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; OINTMENT; PAIN THRESHOLD; PATIENT ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PERIPHERAL NEUROPATHY; PILOT STUDY; POSTHERPETIC NEURALGIA; QUESTIONNAIRE; SCREENING; STATISTICAL ANALYSIS;

EID: 0036993856     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/274631     Document Type: Article

References (27)

1. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
2. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63.
3. Kalichman MW, Calcutt NA. Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology 1992;77:941-7.
4. Catheline G, Kayser V, Idanpaan-Heikkila JJ, Guilbaud G. The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats. Eur J Pharmacol 1996;318:273-81.
5. Puke MJ, Wiesenfeld-Hallin Z. The differential effects of morphine and the alpha 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth Analg 1993;77:104-9.
6. Christensen D, Guilbaud G, Kayser V. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats. Anesthesiology 2000;92:786-94.
7. Hunter JC, Gogas KR, Hedley LR, et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997;324:153-60.
8. Simone DA, Ngeow JY, Putterman GJ, LaMotte RH. Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 1987;418:201-3.
9. Max MB, Portenoy RK, Laska EM, eds. Advances in Pain Research and Therapy: The Design of Analgesic Clinical Trials, vol. 18. New York: Raven Press, Ltd, 1991.
10. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage 2000;20:449-58.
11. Watson CP. The treatment of neuropathic pain: Antidepressants and opioids. Clin J Pain 2000;16(Suppl):S49-55.
12. Ward SE, Goldberg N, Miller-McCauley V, et al. Patient-related barriers to management of cancer pain. Pain 1993;52:319-24.
13. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993;119:121-6.
14. Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 1994;59:201-8.
15. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controolled trial. JAMA 1998;280:1837-42.
16. Edwards KR, Glantz MJ, Button J, et al. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: A double-blind, placebo controlled study. Neurology 2000;54(Suppl):A81. (Abst)
17. Bonica JJ. General considerations of chronic pain. In: JJ Bonica, Ed. The Management of Pain, 2nd edn. London: Lea & Febiger, 1990.
18. Jones MI, Greenfield SM, Bradley CP. Prescribing new drugs: Qualitative study of influences on consultants and general practitioners. BMJ 2001;323:1-7.
19. Davies HT, Crombie IK, Macrae WA. Waiting in pain. Delays between referral and consultation in outpatient pain clinics. Anaesthesia 1994;49:661-5.
20. Knab JH, Wallace MS, Wagner RL, Tsoukatos J, Weinger MB. The use of a computer-based decision support system facilitates primary care physicians' management of chronic pain. Anesth Analg 2001;93:712-20.
21. Smith BH, Hopton JL, Chambers WA. Chronic pain in primary care. Fam Pract 1999;16:475-82.
22. American Society of Anesthesiologists Task Force on Pain Management, Chronic Pain Section. Practice guidelines for chronic pain management. Anethesiology 1997;86:995-1004.
23. Hayes TM, Allery LA, Harding KG, Owen PA. Continuing education for general practice and the role of the pharmaceutical industry. Br J Gen Pract 1990;40:510-2.
24. Boulton AJ, Armstrong WD, Scarpello JH, Ward JD. The natural history of painful diabetic neuropathy - A 4-year study. Postgrad Med J 1983;59:556-9.
25. Glajchen M. Chronic pain: Treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14:211-8.
26. Larue F, Fontaine A, Brasseur L. Evolution of the French public's knowledge and attitudes regarding postoperative pain, cancer pain, and their treatments: Two national surveys over a six-year period. Anesth Analg 1999;89:659-64.
27. Turk DC, Rudy TE. Neglected factors in chronic pain treatment outcome studies - Referral patterns, failure to enter treatment, and attrition. Pain 1990;43:7-25.